TLDR: The function of insulin is the inhibition of lipolysis. Especially via the brain. Where insulin detemir doesn't go.
People will be aware that insulin detemir is really strange stuff. There are perfectly respectable papers showing that it cannot enter the brain (and blocks the entry of normal insulin in to the brain too) or that it is fantastic at entering the brain, much better than more normal insulins.
There are probably more studies in the latter camp but my biases push me towards the former camp. The nature of the researchers also tends to push me towards the former camp. I posted on insulin detemir here and here to explain my point of view.
Now there is this paper:
Euglycemic Infusion of Insulin Detemir Compared With Human Insulin Appears to Increase Direct Current Brain Potential Response and Reduces Food Intake While Inducing Similar Systemic Effects
OK. After an overnight fast, a 90 minute euglycaemic hyperinsulinaemic clamp and a 20 minute wait, subjects consistently eat less food (303kcal, 17% reduction) after an insulin detemir clamp (1475kcal) than they do after a neutral insulin clamp (1782kcal). Just eyeballing the insulin doses used we can assume that the plasma insulin levels were a reasonable approximation for humans in the normal post prandial period, ie physiological fed-state rather than pharmacological.
The research group is completely wedded to the idea that central insulin is an appetite suppressant and that weight gain from any insulin therapy is only a reaction to recurrent hypoglycamia. As there is no hypoglycaemia during the clamps their presumption is that this neutral insulin infusion results in a reduced food intake. As insulin detemir gives less food intake after a normoglycaemic clamp than neutral insulin does, then their conclusion is that insulin detemir is having a more potent central appetite suppressing effect than the neutral insulin.
They are so confident about this that the inclusion of a control situation, where saline was infused without any insulin and appetite was checked after this, was considered un-necessary. This really is the level of research in the "satiety" insulin camp.
Fortunately for us we do still have results from 1985 where food intake after a physiologoical post-prandial level clamp at 150microU/ml for 150 minutes using neutral insulin was compared to saline control and these give us this table cited in a previous post ("liquid drink" is a calorie containing soup-like food):
which allows us to calculate that saline reduces food intake by 40% compared to neutral insulin. Or to rephrase that more plausibly: a clamp using neutral insulin increases food intake by 60%. You can see why a control group was omitted by the "satiety from insulin" paper. I rather like insulin determir compared to any other insulin but you can see it has its work cut out to beat saline as a satiety hormone!
Simplest explanation: Insulin in the brain decreases peripheral lipolysis. This makes you hungry after an hyperinsulinaemic clamp. Insulin detemir doesn't enter the brain so has no CNS augmentation of its peripheral suppressive effect on lipolysis at a given level of glucose control, so it generates less hunger.
I'm a simple sort of a person. That's how I see it. Could be wrong of course.
Peter
Just finished watching Georgia Ede talking about Mood & Memory (https://www.youtube.com/watch?v=O8eR0R3sMHw) and the brains requirements for Insulin, the hippocampus being the most insulin sensitive area. Physiological insulin resistance will reduce the bodies overall demand for glucose during gluconeogenisis, so does this explain the control of the upper limit of GNG and GNG being demand driven as part of hippocampus insulin/glucose balance. Just trying to understand GNG regulation above normoglycaemia.
ReplyDeleteFascinating, thanks!
ReplyDeleteFYI, hyperosmolar saline is not inert.
ReplyDeleteHyperosmolar duodenal saline infusion lowers circulating ghrelin and stimulates intestinal hormone release in young men
https://academic.oup.com/jcem/advance-article-abstract/doi/10.1210/jc.2018-00699/5056321
I didn't scihub this paper, but is there evidence they used hyperosmolar duodenal infusion in the 1985 paper? That would be bizarre if so, typically they would use standard iv normal saline.
DeleteThis comment has been removed by the author.
ReplyDeleteso why is it so hard to figure out what kind of insulin makes it into the brain or not?
ReplyDeleteraphi, it's not. The question is: How do you set the experiment up to get the results you need? Like the anorectic effect of CNS insulin. This happens every time when certain labs perform the injection. But never in Novo Nordisk's lab. Repeatedly. How does this happen?
ReplyDeleteerdoke, yep. Just pubmed hypertonic saline and look what it does intravenously.
Colin, the "central insulin drives white adipose tissue expansion" group has a certain amount to say about glycerol plus lots of NADH = gluconeogenesis, ie glucose from fat. They describe elevated FFAs as controlling hepatic GNG. A concept I like. Again, how you set up the experiment might be quite important.
Peter
someone should point this out to Guyenet (assuming they're idealistic enough to presume it may re-focus his skepticism)
ReplyDeleteraphi!!!! Go and wash your mouth out with soap and water! Peter shakes head in astonishment that anyone might do anything so useless. Like fitting indicators to BMWs...
ReplyDeletePeter
Insulin, the magic backwards hormone that makes people hungry by being absent. The mind boggles.
ReplyDelete